Top 15 Companies in Global Active B12 Test 2025: Market Intelligence & Investment Trends (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, the Global Active B12 Test Market Size is projected to grow from USD 3.76 Million in 2024 to USD 20.28 Million by 2035, at a CAGR of 16.56% during the forecast period 2024–2035. The global active B12 test market is growing due to increasing awareness of vitamin B12 deficiency, rising adoption of advanced diagnostic technologies, expanding applications in clinical and wellness testing, and supportive healthcare regulations, which are driving adoption across multiple industries and supporting overall market expansion.
Introduction
The active B12 test market consists of diagnostic solutions which measure the active vitamin B12 form called holotranscobalamin through blood testing to identify deficiencies with exact precision. The tests use three different methods which include immunoassays and ELISA kits and automated laboratory analyzers to measure biologically active B12 with exact precision. Active B12 testing serves multiple purposes which include clinical diagnostics and preventive healthcare and nutritional assessment and wellness monitoring and research laboratories. The market experiences growth because people increasingly understand vitamin B12 deficiency and health problems rise and advanced diagnostic technologies become more common. Recent innovations include testing which has high sensitivity and devices for quick point-of-care testing and systems which connect with digital health platforms to deliver results in faster and more dependable ways. The upcoming years will see preventive medicine and routine health screenings and wellness monitoring programs become standard practice throughout the world.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the active B12 test market.
Global Active B12 Test Market Size & Statistics
- The Market Size for Active B12 Test Was Estimated to be worth USD 3.76 Million in 2024.
- The Market is Going to Expand at a CAGR of 16.56% between 2024 and 2035.
- The Global Active B12 Test Market Size is anticipated to reach USD 20.28 Million by 2035.
- North America is expected to generate the largest demand during the forecast period in the Active B12 Test Market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Active B12 Test Market.
Regional Growth and Demand
Asia Pacific is expected to grow the fastest during the forecast period in the active B12 test market. Asia Pacific is the most rapidly expanding Active B12 Test market, driven by rising awareness of vitamin B12 deficiency, increasing adoption of advanced diagnostic technologies, and expanding healthcare infrastructure. Companies such as Roche, Abbott, Siemens Healthineers, and Bio-Rad Laboratories are investing in innovative testing solutions, while government health initiatives and growing local diagnostic networks are creating highly profitable opportunities for regional and international providers.
North America is expected to generate the largest demand during the forecast period in the active B12 test market. The market is dominated by North America, with established clinical laboratories, widespread adoption of automated diagnostics, and strong preventive healthcare programs. Leading players such as Roche, Abbott, Siemens Healthineers, and Beckman Coulter drive innovation and maintain extensive distribution networks, making the region a center for advanced B12 testing solutions globally.
Top 10 Trends in the Active B12 Test Market
- Adoption of Point-of-Care Testing
- Integration with Digital Health Platforms
- Expansion of Home-Based Testing Kits
- Automation in Laboratory Diagnostics
- Integration of Artificial Intelligence (AI)
- Rising Focus on Preventive Healthcare
- Use in Prenatal and Maternal Health Programs
- Integration with Telemedicine Services
- Development of Multiplex Testing Panels
- Emergence of High-Sensitivity Assays
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the active B12 test market.
1. Adoption of Point-of-Care Testing
The growing adoption of point-of-care testing drives the Active B12 Test market by enabling rapid, on-site assessment of vitamin B12 levels. This trend improves patient convenience, timely diagnosis, and treatment decisions, enhancing healthcare efficiency across clinics, hospitals, and remote or underserved locations globally.
2. Integration with Digital Health Platforms
The integration of Active B12 Tests with digital health platforms allows seamless data collection, real-time monitoring, and remote analysis. This trend improves patient management, enhances healthcare provider insights, and supports large-scale population health initiatives through centralized, connected digital systems.
3. Expansion of Home-Based Testing Kits
The rising availability of home-based Active B12 Test kits supports convenient self-testing and early detection. This trend enhances patient autonomy, reduces healthcare facility visits, and increases overall testing penetration, promoting proactive healthcare and broader adoption across health-conscious populations.
4. Automation in Laboratory Diagnostics
Automation in laboratory Active B12 testing accelerates sample processing, minimizes errors, and ensures consistent, high-throughput analysis. This trend improves laboratory efficiency, accuracy, and operational scalability, supporting hospitals, diagnostic centers, and research laboratories in delivering timely, reliable results.
5. Integration of Artificial Intelligence (AI)
The integration of AI in Active B12 testing enables predictive analytics, pattern recognition, and data-driven diagnostics. This trend enhances result accuracy, supports clinical decision-making, and improves operational efficiency, allowing healthcare providers to deliver personalized and evidence-based care with optimized workflows.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the active B12 test market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 15 Companies Leading the Active B12 Test Market
- Axis-Shield Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Roche Diagnostics
- DiaSorin S.p.A.
- LifeSpan BioSciences, Inc.
- Demeditec Diagnostics GmbH
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific
- Metropolis Healthcare Ltd.
- Australian Clinical Labs
- Pathkind Diagnostics Pvt. Ltd.
- Ortho Clinical Diagnostics
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the active B12 test market.
1. Axis-Shield Diagnostics
Headquarters: Dundee, United Kingdom
Axis-Shield Diagnostics is a leading provider of diagnostic solutions, specializing in the development of the Active-B12 (Holotranscobalamin) assay. In the Active B12 Test market, the company delivers high-precision testing kits for clinical and laboratory use. Axis-Shield’s solutions enable accurate assessment of vitamin B12 status, supporting preventive healthcare and patient management. Its innovations in assay design and automation enhance test efficiency, reliability, and adoption across hospitals, diagnostic labs, and research institutions globally.
2. Abbott Laboratories
Headquarters: Abbott Park, Illinois, USA
Abbott Laboratories is a global healthcare company offering advanced immunoassay analyzers, including Active B12 testing solutions. In the Active B12 Test market, Abbott provides automated systems for serum B12 measurement in clinical laboratories. Its technology ensures precise and reproducible results, supporting early diagnosis and patient care. Abbott’s integration of advanced analytics and workflow automation enhances laboratory efficiency, standardization, and accessibility, driving the adoption of Active B12 testing across hospitals, diagnostic centers, and research facilities worldwide.
3. Siemens Healthineers
Headquarters: Erlangen, Germany
Siemens Healthineers is a leading medical technology company providing automated serum B12 assays and immunodiagnostic solutions. In the Active B12 Test market, it offers highly reliable testing platforms for clinical and laboratory applications. Siemens’ solutions enhance testing throughput, accuracy, and diagnostic decision-making. Through continuous innovation in automation, software integration, and assay design, Siemens contributes to improving laboratory productivity, scalability, and the global adoption of Active B12 testing across healthcare providers, hospitals, and research institutions.
4. Roche Diagnostics
Headquarters: Basel, Switzerland
Roche Diagnostics specializes in clinical diagnostics and immunoassays, including the Elecsys Active B12 (Holotranscobalamin) assay. In the Active B12 Test market, Roche delivers high-sensitivity and rapid testing solutions for laboratory and hospital settings. Its platforms enable precise measurement of vitamin B12 status, supporting preventive care and clinical decision-making. Roche’s integration of automation, high-throughput systems, and advanced analytics improves operational efficiency, reliability, and accessibility, driving global adoption of Active B12 testing technologies in healthcare and research sectors.
5. DiaSorin S.p.A.
Headquarters: Saluggia, Italy
DiaSorin S.p.A. is a specialist in immunodiagnostic tests, offering products for vitamins and nutritional markers, including Active B12 assays. In the Active B12 Test market, the company provides reliable ELISA-based and automated platforms for clinical laboratories. DiaSorin’s solutions support early detection of vitamin B12 deficiencies and accurate patient monitoring. Through innovation in assay development, automation, and laboratory workflow integration, DiaSorin enhances testing efficiency, precision, and adoption, contributing to improved healthcare outcomes and global growth of the Active B12 Test market.
Are you ready to discover more about the active B12 test market?
The report provides an in-depth analysis of the leading companies operating in the global active B12 test market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Axis-Shield Diagnostics
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Abbott Laboratories
- Siemens Healthineers
- Roche Diagnostics
- DiaSorin S.p.A.
- LifeSpan BioSciences, Inc.
- Demeditec Diagnostics GmbH
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- Others
Our Reports
https://www.sphericalinsights.com/reports/dinitrochlorobenzene-market
https://www.sphericalinsights.com/reports/oleic-acid-market
https://www.sphericalinsights.com/reports/low-density-polyethylene-market
Conclusion
The active B12 test market provides facilities for accurate assessment of biologically active vitamin B12 which serves clinical diagnostics and preventive healthcare and wellness tracking and research laboratory needs to enable early patient diagnosis and treatment. The market drivers include increasing understanding of B12 deficiency combined with the implementation of advanced immunoassays and the growth of home-based testing and point-of-care testing and the connection to digital health and AI systems. The main industry developments focus on high-sensitivity testing methods and automated laboratory systems and artificial intelligence based analytical solutions. North America maintains its market leadership because of Roche Diagnostics and Abbott Laboratories while Asia-Pacific shows strong market growth. The main companies in the industry are Siemens Healthineers and Axis-Shield Diagnostics and Bio-Rad Laboratories.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the active B12 test market.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?